UCB - Assets

Stock Price
261.00
Daily Change
0.40 0.15%
Monthly
11.11%
Yearly
41.46%
Q1 Forecast
249.19

UCB reported EUR17.35B in Assets for its fiscal semester ending in December of 2024.





Assets Change Date
Alcon AG USD 31.52B 137M Sep/2025
Almirall EUR 2.31B 88.74M Jun/2025
Amarin USD 659.81M 10.31M Sep/2025
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Galapagos EUR 3.51B 306.31M Sep/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
GRIFOLS EUR 19.85B 86.61M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 50.93B 3.58B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Orion EUR 1.75B 102.1M Sep/2025
Recordati EUR 5.3B 122.58M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 17.35B 1.72B Dec/2024
Unibail Rodamco EUR 53.55B 298.5M Dec/2024